Knight Diagnostic Laboratories’ researchers contributed to an article in the November publication of Blood

OHSU and Knight Diagnostic Laboratories’ researchers contributed to an article in the November publication of Blood:  The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia. O'Hare T, Zabriskie MS, Eide CA, Agarwal A, Adrian LT, You H, Corbin AS, Yang F, Press RD, Rivera VM, Toplin J, Wong S, Deininger MW, Druker BJ. Blood. 2011 Nov 10;118(19):5250-4.